Who Will Join Us? EU Regulators Seek Feedback On Proposed Clinical Trials Discussion Platform

Regulators want to know who is interested in joining their planned multi-stakeholder platform for discussions on how to improve clinical trials in Europe. They are also seeking feedback on which topics should be prioritized for discussion.

hybrid meeting
The proposed multi-stakeholder meetings could take place virtually or in a hybrid format • Source: Shutterstock

Drug companies, health technology assessment bodies, ethicists and patient groups are among the raft of stakeholders that can now have their say on the multi-stakeholder platform (MSP) that EU regulators want to set up this year to enable discussions on improving Europe’s clinical trials landscape.

The MSP’s establishment is described in a concept paper that the European Medicines Agency, the EU’s Heads of Medicines Agencies...

More from Europe

More from Geography